We are live on ! Find out more
GFA

Gallagher Fiduciary Advisors Portfolio holdings

AUM $2.58B
1-Year Est. Return 8.97%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+8.97%
3 Year Est. Return
+33.7%
5 Year Est. Return
+56.28%
10 Year Est. Return
+54.68%
AUM
$511M
AUM Growth
+$17.1M
Cap. Flow
+$22.9M
Cap. Flow %
4.49%
Top 10 Hldgs %
42.4%
Holding
307
New
33
Increased
215
Reduced
36
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 4.43%
2 Financials 4.14%
3 Consumer Discretionary 3.02%
4 Industrials 2.24%
5 Communication Services 2.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MP icon
276
MP Materials
MP
$9.73B
$209K 0.04%
13,400
-200
-1% -$3.71K
BRSP
277
BrightSpire Capital
BRSP
$620M
$204K 0.04%
36,164
+5,749
+19% +$34K
FVD icon
278
First Trust Value Line Dividend Fund
FVD
$8.35B
$202K 0.04%
+4,627
New +$209K
PWS icon
279
Pacer WealthShield ETF
PWS
$24.8M
$201K 0.04%
6,623
REI icon
280
Ring Energy
REI
$354M
$199K 0.04%
146,272
+2,765
+2% +$4.15K
DAN icon
281
Dana Inc
DAN
$3.21B
$196K 0.04%
16,986
+2,771
+19% +$28.8K
NEOG icon
282
Neogen
NEOG
$2.49B
$191K 0.04%
15,715
+597
+4% +$8.35K
GT icon
283
Goodyear
GT
$1.74B
$187K 0.04%
20,778
+2,418
+13% +$22.1K
AMCX icon
284
AMC Global Media
AMCX
$489M
$185K 0.04%
18,659
+2,770
+17% +$24.5K
GTN icon
285
Gray Television
GTN
$512M
$170K 0.03%
54,118
+1,949
+4% +$9.1K
BKD icon
286
Brookdale Senior Living
BKD
$3.27B
$170K 0.03%
33,864
+1,516
+5% +$8.68K
PLRX icon
287
Pliant Therapeutics
PLRX
$64.4M
$157K 0.03%
11,889
+1,880
+19% +$25.7K
DBRG icon
288
DigitalBridge
DBRG
$2.95B
$150K 0.03%
13,285
+414
+3% +$5.57K
MQ icon
289
Marqeta
MQ
$1.62B
$144K 0.03%
9,491
+277
+3% +$4.86K
OABI icon
290
OmniAb
OABI
$491M
$130K 0.03%
36,752
+1,657
+5% +$6.56K
PTEN icon
291
Patterson-UTI
PTEN
$4.19B
$123K 0.02%
14,856
+1,731
+13% +$13.9K
CMTG icon
292
Claros Mortgage Trust
CMTG
$250M
$101K 0.02%
22,431
+611
+3% +$3.81K
STNE icon
293
StoneCo
STNE
$2.52B
$100K 0.02%
12,589
+490
+4% +$4.97K
PSNY icon
294
Polestar Automotive Holding UK
PSNY
$2.01B
$98.2K 0.02%
3,117
-13
-0.4% -$471
ACB
295
Aurora Cannabis
ACB
$179M
$86.2K 0.02%
20,280
+450
+2% +$2.21K
CHPT icon
296
ChargePoint
CHPT
$158M
$42.9K 0.01%
2,005
-3
-0.1% -$74
PACB icon
297
Pacific Biosciences
PACB
$357M
$31.2K 0.01%
17,050
+3,104
+22% +$6.06K
MJ icon
298
Amplify Alternative Harvest ETF
MJ
$105M
$26.3K 0.01%
979
-188
-16% -$6.29K
ANIK icon
299
Anika Therapeutics
ANIK
$277M
-8,809
Closed -$218K
ASML icon
300
ASML
ASML
$666B
-241
Closed -$201K

Similar funds

Gallagher Fiduciary Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Gallagher Fiduciary Advisors held 307 positions worth $511M, up 3.5% from $494M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Gallagher Fiduciary Advisors deployed $22.9M of net new capital in Q4 2024, opening 33 new positions and adding to 215 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 2,471 shares worth $1.33M.

By sector, the portfolio is most concentrated in Technology at 4.4% of assets, up from 3.8% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $4.89M trimmed.

  • Gallagher Fiduciary Advisors's largest Q4 2024 buy was Vanguard S&P 500 ETF: 2,471 shares worth $1.33M.
  • Gallagher Fiduciary Advisors added most to Vanguard Morningstar Growth ETF in Q4 2024, an estimated $6.04M increase.
  • Gallagher Fiduciary Advisors's biggest Q4 2024 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $4.89M.
  • Gallagher Fiduciary Advisors fully exited Fastenal in Q4 2024, selling an estimated $306K.
  • Gallagher Fiduciary Advisors's ten largest holdings make up 42% of its $511M portfolio in Q4 2024.
  • Gallagher Fiduciary Advisors opened 33 new positions and closed 9 in Q4 2024.
  • Gallagher Fiduciary Advisors's portfolio value rose 3.5% quarter-over-quarter to $511M.

Based on Gallagher Fiduciary Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.